The hearing of New Horizon Health's (HKG:6606) joint provisional liquidator application with the Grand Court of the Cayman Islands has been scheduled at 10 am on Aug. 6, a Friday Hong Kong bourse filing said.
The cancer screening test developer had filed the application in early July.
If appointed, the joint provisional liquidators will conduct investigations into the firm's affairs, in particular, certain concerns raised by the company's auditors in relation to its 2023 annual results.
The auditor raised questions on the validity of certain sales transactions, as well as marketing and selling expenses among other things, according to a March 2024 disclosure.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。